This compound, featuring an amino group and a methanesulfonyl group on a pyrrolidine ring, is primarily used as an intermediate in the synthesis of various pharmaceuticals, particularly those targeting neurological and psychiatric disorders. Its molecular structure allows for modifications to enhance efficacy and specificity in biological activity, making it valuable in designing enzyme inhibitors and therapeutic agents. Additionally, it is employed in the preparation of active pharmaceutical ingredients (APIs) and studied for applications in agricultural chemicals and as an aid in biochemical research.